These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33016891)

  • 1. Enhancing the Clinical Utility of DriveSafe DriveAware for People with Huntington's Disease.
    Sondhu MK; Fisher F; Stout JC
    J Huntingtons Dis; 2020; 9(4):353-357. PubMed ID: 33016891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive Fitness to Drive in Huntington's Disease: Assessing the Clinical Utility of DriveSafe DriveAware.
    Farrell HJ; Andrews SC; Ryan NP; Davis MC; Gordon S; Stout JC; Fisher F
    J Huntingtons Dis; 2019; 8(1):87-95. PubMed ID: 30776017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test-retest reliability of touchscreen DriveSafe DriveAware.
    Johnston BJ; O'Donnell JM; Manuguerra M; Davidson AS
    Aust Occup Ther J; 2021 Apr; 68(2):106-114. PubMed ID: 33368324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting driving ability using DriveSafe and DriveAware in people with cognitive impairments: a replication study.
    Hines A; Bundy AC
    Aust Occup Ther J; 2014 Aug; 61(4):224-9. PubMed ID: 24762200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of simulated driving performance in Huntington's disease.
    Jacobs M; Hart EP; Mejia Miranda Y; Groeneveld GJ; van Gerven JMA; Roos RAC
    Parkinsonism Relat Disord; 2019 Mar; 60():64-69. PubMed ID: 30292732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Fitness to Drive for Medically At-Risk Drivers Using Touchscreen DriveSafe DriveAware.
    Cheal B; Bundy A; Patomella AH; Kuang H; Scanlan JN
    Am J Occup Ther; 2023 Jan; 77(1):. PubMed ID: 36716210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. We can predict when driving is no longer safe for people who have HD using standard neuropsychological measures.
    Hennig BL; Kaplan RF; Nowicki AE; Barclay JE; Gertsberg AG
    J Huntingtons Dis; 2014; 3(4):351-3. PubMed ID: 25575956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automobile driving in Huntington's disease.
    Rebok GW; Bylsma FW; Keyl PM; Brandt J; Folstein SE
    Mov Disord; 1995 Nov; 10(6):778-87. PubMed ID: 8749997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered driving performance of symptomatic Huntington's disease gene carriers in simulated road conditions.
    Jacobs M; Hart EP; Miranda YM; Groeneveld GJ; van Gerven JMA; Roos RAC
    Traffic Inj Prev; 2018; 19(7):708-714. PubMed ID: 30273496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DriveSafe DriveAware: A systematic review.
    Vito E; Barkla A; Coventry L
    Australas J Ageing; 2023 Mar; 42(1):53-63. PubMed ID: 36602154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of fitness to drive in Huntington disease.
    Devos H; Nieuwboer A; Tant M; De Weerdt W; Vandenberghe W
    Neurology; 2012 Nov; 79(19):1975-82. PubMed ID: 23100397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive Dysfunction Contributes to Mobility Impairments in Huntington's Disease.
    Kloos AD; Kegelmeyer DA; Fritz NE; Daley AM; Young GS; Kostyk SK
    J Huntingtons Dis; 2017; 6(4):363-370. PubMed ID: 29254103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How effective is the Trail Making Test (Parts A and B) in identifying cognitively impaired drivers?
    Dobbs BM; Shergill SS
    Age Ageing; 2013 Sep; 42(5):577-81. PubMed ID: 23896609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors of driving status in Huntington's disease.
    Beglinger LJ; Prest L; Mills JA; Paulsen JS; Smith MM; Gonzalez-Alegre P; Rowe KC; Nopoulos P; Uc EY
    Mov Disord; 2012 Aug; 27(9):1146-52. PubMed ID: 22744778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DriveSafe and DriveAware Assessment Tools Are a Measure of Driving-Related Function and Predicts Self-Reported Restriction for Older Drivers.
    Allan C; Coxon K; Bundy A; Peattie L; Keay L
    J Appl Gerontol; 2016 Jun; 35(6):583-600. PubMed ID: 25724948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting fitness to drive in people with cognitive impairments by using DriveSafe and DriveAware.
    Kay LG; Bundy AC; Clemson LM
    Arch Phys Med Rehabil; 2009 Sep; 90(9):1514-22. PubMed ID: 19735779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering Cognitive Impairments in Huntington's Disease: A Comparative Study of Stroop Test Variations.
    Sierra LA; Wynn A; Lanzaro E; Dzekon K; Russell A; Halko M; Claassen DO; Frank S; Considine CM; Laganiere S
    J Huntingtons Dis; 2024; 13(2):249-257. PubMed ID: 38759020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive Performance After a One-Year Multidisciplinary Intensive Rehabilitation Program for Huntington's Disease: An Observational Study.
    van Walsem MR; Piira A; Mikalsen G; Fossmo HL; Howe EI; Knutsen SF; Frich JC
    J Huntingtons Dis; 2018; 7(4):379-389. PubMed ID: 30320595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On-road driving impairments in Huntington disease.
    Devos H; Nieuwboer A; Vandenberghe W; Tant M; De Weerdt W; Uc EY
    Neurology; 2014 Mar; 82(11):956-62. PubMed ID: 24523484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of Brief Screening Tools to Identify Impaired Driving Among Older Adults in Australia.
    Anstey KJ; Eramudugolla R; Huque MH; Horswill M; Kiely K; Black A; Wood J
    JAMA Netw Open; 2020 Jun; 3(6):e208263. PubMed ID: 32585021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.